Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Methotrexate Solution, 1.0 mg/mL in Methanol with 0.1N NaOH, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001626 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-626 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-626 Supplier MilliporeSigma Supelco Supplier No. M1361ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

A Certified Spiking Solution™ for use in therapeutic drug monitoring (TDM) analyses by HPLC or LC/MS. Used in the treatment of cancer and autoimmune diseases, methotrexate is an antimetabolite and antifolate drug monitored by clinical labs to ensure patients remain within the drug's therapeutic range. The Snap-N-Spike™ format allows laboratories to eliminate weighing operations of hazardous substances such as methotrexate, significantly reducing occupational exposure hazards related to handling of acutely toxic powders, and provides the ability to spike into their matrix of choice just before use.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 59-05-2
Linear Formula C20H22N8O5
MDL Number MFCD00064369
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 1.0 mg/mL in methanol with 0.1N NaOH
Formula Weight 454.44
Packaging Ampule
Quantity 1 mL
Flash Point 11°C (51.8°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.